Literature DB >> 16103206

Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.

Masahiro Kobayashi1, Hiroko Igarashi, Akiko Takeda, Moriaki Kato, Tetsuro Matano.   

Abstract

Vaccine-based control of the replication of a simian immunodeficiency virus (SIV), SIVmac239, in macaques has recently been shown. In the process of the control, a mutant virus escaping from epitope-specific cytotoxic-T-lymphocyte (CTL) responses was rapidly selected and contained. In this study, we show that the wild-type virus appeared and became predominant in the absence of the epitope-specific CTL after inoculation of naive macaques with a molecular clone DNA of the CTL escape mutant SIV. This is the first report describing reversion in vivo from an inoculated, molecular proviral DNA clone of immunodeficiency virus with a CTL escape mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103206      PMCID: PMC1193606          DOI: 10.1128/JVI.79.17.11529-11532.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  HIV vaccines 1983-2003.

Authors:  Andrew J McMichael; Tomas Hanke
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 2.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

3.  Reversion of CTL escape-variant immunodeficiency viruses in vivo.

Authors:  Thomas C Friedrich; Elizabeth J Dodds; Levi J Yant; Lara Vojnov; Richard Rudersdorf; Candice Cullen; David T Evans; Ronald C Desrosiers; Bianca R Mothé; John Sidney; Alessandro Sette; Kevin Kunstman; Steven Wolinsky; Michael Piatak; Jeffrey Lifson; Austin L Hughes; Nancy Wilson; David H O'Connor; David I Watkins
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

4.  Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response.

Authors:  Thomas C Friedrich; Christopher A Frye; Levi J Yant; David H O'Connor; Nancy A Kriewaldt; Meghan Benson; Lara Vojnov; Elizabeth J Dodds; Candice Cullen; Richard Rudersdorf; Austin L Hughes; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

6.  Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.

Authors:  Dan H Barouch; Jennifer Powers; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Fred W Peyerl; Marcelo J Kuroda; Darci A Gorgone; Michelle A Lifton; Carol I Lord; Vanessa M Hirsch; David C Montefiori; Angela Carville; Keith G Mansfield; Kevin J Kunstman; Steven M Wolinsky; Norman L Letvin
Journal:  Nat Immunol       Date:  2005-01-30       Impact factor: 25.606

7.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

8.  HIV evolution: CTL escape mutation and reversion after transmission.

Authors:  A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

9.  Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope.

Authors:  Fred W Peyerl; Dan H Barouch; Wendy W Yeh; Heidi S Bazick; Jennifer Kunstman; Kevin J Kunstman; Steven M Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  20 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.

Authors:  Miki Kawada; Hiroko Igarashi; Akiko Takeda; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Sachi Dohki; Masafumi Takiguchi; Tetsuro Matano
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.

Authors:  Nicholas J Maness; Levi J Yant; Chungwon Chung; John T Loffredo; Thomas C Friedrich; Shari M Piaskowski; Jessica Furlott; Gemma E May; Taeko Soma; Enrique J León; Nancy A Wilson; Helen Piontkivska; Austin L Hughes; John Sidney; Alessandro Sette; David I Watkins
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

4.  Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.

Authors:  Miki Kawada; Tetsuo Tsukamoto; Hiroyuki Yamamoto; Nami Iwamoto; Kyoko Kurihara; Akiko Takeda; Chikaya Moriya; Hiroaki Takeuchi; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

5.  Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.

Authors:  Christina F Thobakgale; Andrew Prendergast; Hayley Crawford; Nompumelelo Mkhwanazi; Danni Ramduth; Sharon Reddy; Claudia Molina; Zenele Mncube; Alasdair Leslie; Julia Prado; Fundi Chonco; Wendy Mphatshwe; Gareth Tudor-Williams; Prakash Jeena; Natasha Blanckenberg; Krista Dong; Photini Kiepiela; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

6.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25

7.  Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.

Authors:  Anju Bansal; Ling Yue; Joan Conway; Karina Yusim; Jianming Tang; John Kappes; Richard A Kaslow; Craig M Wilson; Paul A Goepfert
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

8.  Transmission of simian immunodeficiency virus carrying multiple cytotoxic T-lymphocyte escape mutations with diminished replicative ability can result in AIDS progression in rhesus macaques.

Authors:  Sayuri Seki; Miki Kawada; Akiko Takeda; Hiroko Igarashi; Tetsutaro Sata; Tetsuro Matano
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.

Authors:  Philippa C Matthews; Andrew Prendergast; Alasdair Leslie; Hayley Crawford; Rebecca Payne; Christine Rousseau; Morgane Rolland; Isobella Honeyborne; Jonathan Carlson; Carl Kadie; Christian Brander; Karen Bishop; Nonkululeko Mlotshwa; James I Mullins; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

Review 10.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.